BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34342378)

  • 1. Predicting Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate Therapy: Development and International Validation of Prognostic Models.
    Khalid S; Pineda-Moncusí M; El-Hussein L; Delmestri A; Ernst M; Smith C; Libanati C; Toth E; Javaid MK; Cooper C; Abrahamsen B; Prieto-Alhambra D
    J Bone Miner Res; 2021 Nov; 36(11):2162-2176. PubMed ID: 34342378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real-World Data From the UK.
    Pineda-Moncusí M; El-Hussein L; Delmestri A; Cooper C; Moayyeri A; Libanati C; Toth E; Prieto-Alhambra D; Khalid S
    J Bone Miner Res; 2022 Oct; 37(10):1986-1996. PubMed ID: 35818312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data.
    Khalid S; Reyes C; Ernst M; Delmestri A; Toth E; Libanati C; Abrahamsen B; Prieto-Alhambra D
    Osteoporos Int; 2022 Jan; 33(1):123-137. PubMed ID: 34392386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Osteoporotic Fractures in Elderly Individuals: A Derivation and Internal Validation Study Using Healthcare Administrative Data.
    Beaudoin C; Jean S; Moore L; Gamache P; Bessette L; Ste-Marie LG; Brown JP
    J Bone Miner Res; 2021 Dec; 36(12):2329-2342. PubMed ID: 34490952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort.
    Iconaru L; Charles A; Baleanu F; Surquin M; Benoit F; Mugisha A; Moreau M; Paesmans M; Karmali R; Rubinstein M; Rozenberg S; Body JJ; Bergmann P
    J Bone Miner Res; 2022 Jan; 37(1):59-67. PubMed ID: 34490908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
    Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
    BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of FRISBEE 5-year fracture prediction models: a registry-based cohort study.
    Agarwal A; Baleanu F; Moreau M; Charles A; Iconaru L; Surquin M; Benoit F; Paesmans M; Karmali R; Bergmann P; Body JJ; Leslie WD
    Arch Osteoporos; 2022 Dec; 18(1):13. PubMed ID: 36564674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
    Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
    Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.
    Olsen KR; Hansen C; Abrahamsen B
    Osteoporos Int; 2013 Oct; 24(10):2639-47. PubMed ID: 23604250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
    Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and external validation of a 1- and 5-year fracture prediction tool based on electronic medical records data: The EPIC risk algorithm.
    Tebé C; Pallarès N; Reyes C; Carbonell-Abella C; Montero-Corominas D; Martín-Merino E; Nogués X; Diez-Perez A; Prieto-Alhambra D; Martínez-Laguna D
    Bone; 2022 Sep; 162():116469. PubMed ID: 35691583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
    N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Fracture Risk Assessment Tool (FREM) Based on Public Health Registries.
    Rubin KH; Möller S; Holmberg T; Bliddal M; Søndergaard J; Abrahamsen B
    J Bone Miner Res; 2018 Nov; 33(11):1967-1979. PubMed ID: 29924428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
    Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate use after clinical fracture and risk of new fracture.
    Bergman J; Nordström A; Nordström P
    Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for older men with fractures.
    Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
    Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.